Breaking News, Collaborations & Alliances

Sartorius, RoosterBio Partner to Advance the Manufacture of Exosomes

Aims to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sartorius has extended a strategic collaboration agreement with RoosterBio Inc. to address purification challenges and establish scalable downstream manufacturing processes for exosome-based therapies. The companies will provide solutions and expertise for a human mesenchymal stem/stromal cell (hMSC) – based exosome production platform that aims to deliver industry-leading yield, purity, and potency. This collaboration will also focus on the development of comprehensive analytical techniqu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters